Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes.

Ashwood P, Enstrom A, Krakowiak P, Hertz-Picciotto I, Hansen RL, Croen LA, Ozonoff S, Pessah IN, Van de Water J.

J Neuroimmunol. 2008 Nov 15;204(1-2):149-53. doi: 10.1016/j.jneuroim.2008.07.006.

2.

Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.

Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J.

Brain Behav Immun. 2011 Jan;25(1):40-5. doi: 10.1016/j.bbi.2010.08.003. Epub 2010 Aug 10.

3.

Decreased serum levels of transforming growth factor-beta1 in patients with autism.

Okada K, Hashimoto K, Iwata Y, Nakamura K, Tsujii M, Tsuchiya KJ, Sekine Y, Suda S, Suzuki K, Sugihara G, Matsuzaki H, Sugiyama T, Kawai M, Minabe Y, Takei N, Mori N.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):187-90. Epub 2006 Oct 6.

PMID:
17030376
4.

Brief report: plasma leptin levels are elevated in autism: association with early onset phenotype?

Ashwood P, Kwong C, Hansen R, Hertz-Picciotto I, Croen L, Krakowiak P, Walker W, Pessah IN, Van de Water J.

J Autism Dev Disord. 2008 Jan;38(1):169-75. Epub 2007 Mar 9.

PMID:
17347881
5.

Prevalence of motor impairment in autism spectrum disorders.

Ming X, Brimacombe M, Wagner GC.

Brain Dev. 2007 Oct;29(9):565-70. Epub 2007 Apr 30.

PMID:
17467940
6.

Altered gene expression and function of peripheral blood natural killer cells in children with autism.

Enstrom AM, Lit L, Onore CE, Gregg JP, Hansen RL, Pessah IN, Hertz-Picciotto I, Van de Water JA, Sharp FR, Ashwood P.

Brain Behav Immun. 2009 Jan;23(1):124-33. doi: 10.1016/j.bbi.2008.08.001. Epub 2008 Aug 14.

7.

Increased anti-phospholipid antibodies in autism spectrum disorders.

Careaga M, Hansen RL, Hertz-Piccotto I, Van de Water J, Ashwood P.

Mediators Inflamm. 2013;2013:935608. doi: 10.1155/2013/935608. Epub 2013 Sep 23.

8.

A cleanroom sleeping environment's impact on markers of oxidative stress, immune dysregulation, and behavior in children with autism spectrum disorders.

Faber S, Zinn GM, Boggess A, Fahrenholz T, Kern JC 2nd, Kingston HM.

BMC Complement Altern Med. 2015 Mar 19;15:71. doi: 10.1186/s12906-015-0564-0.

9.

Altered T cell responses in children with autism.

Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water J.

Brain Behav Immun. 2011 Jul;25(5):840-9. doi: 10.1016/j.bbi.2010.09.002. Epub 2010 Sep 15.

10.
11.

Immune dysregulation in autism spectrum disorder.

Noriega DB, Savelkoul HF.

Eur J Pediatr. 2014 Jan;173(1):33-43. doi: 10.1007/s00431-013-2183-4. Epub 2013 Dec 3. Review.

12.

Increased IgG4 levels in children with autism disorder.

Enstrom A, Krakowiak P, Onore C, Pessah IN, Hertz-Picciotto I, Hansen RL, Van de Water JA, Ashwood P.

Brain Behav Immun. 2009 Mar;23(3):389-95. doi: 10.1016/j.bbi.2008.12.005. Epub 2008 Dec 25.

13.

Immune dysregulation in autism spectrum disorder.

Hsiao EY.

Int Rev Neurobiol. 2013;113:269-302. doi: 10.1016/B978-0-12-418700-9.00009-5. Review.

14.

Developmental and behavioral questionnaire for autism spectrum disorders.

McGrew S, Malow BA, Henderson L, Wang L, Song Y, Stone WL.

Pediatr Neurol. 2007 Aug;37(2):108-16.

PMID:
17675025
15.

Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008.

Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control and Prevention.

MMWR Surveill Summ. 2012 Mar 30;61(3):1-19.

16.

Variation in early developmental course in autism and its relation with behavioral outcome at 3-4 years of age.

Werner E, Dawson G, Munson J, Osterling J.

J Autism Dev Disord. 2005 Jun;35(3):337-50.

PMID:
16119475
17.

Mitochondrial DNA and anti-mitochondrial antibodies in serum of autistic children.

Zhang B, Angelidou A, Alysandratos KD, Vasiadi M, Francis K, Asadi S, Theoharides A, Sideri K, Lykouras L, Kalogeromitros D, Theoharides TC.

J Neuroinflammation. 2010 Nov 17;7:80. doi: 10.1186/1742-2094-7-80.

18.

Association of IL-12p70 and IL-6:IL-10 ratio with autism-related behaviors in 22q11.2 deletion syndrome: a preliminary report.

Ross HE, Guo Y, Coleman K, Ousley O, Miller AH.

Brain Behav Immun. 2013 Jul;31:76-81. doi: 10.1016/j.bbi.2012.12.021. Epub 2013 Jan 24.

19.

Maternal immune-mediated conditions, autism spectrum disorders, and developmental delay.

Lyall K, Ashwood P, Van de Water J, Hertz-Picciotto I.

J Autism Dev Disord. 2014 Jul;44(7):1546-55. doi: 10.1007/s10803-013-2017-2.

Supplemental Content

Support Center